Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Medexus Pharmaceuticals Inc (MEDXF)

Medexus Pharmaceuticals Inc (MEDXF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade MEDXF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.7300 +2.71%
on 07/30/21
6.7900 -13.33%
on 07/19/21
-0.0350 (-0.59%)
since 06/30/21
3-Month
5.4850 +7.29%
on 06/22/21
6.7900 -13.33%
on 07/19/21
-0.2900 (-4.70%)
since 04/30/21
52-Week
2.0100 +192.79%
on 10/12/20
7.7600 -24.16%
on 02/17/21
+2.9350 (+99.49%)
since 07/30/20

Most Recent Stories

More News
Medexus Appoints New Chief Financial Officer

Medexus Pharmaceuticals Inc. ("Medexus" or the "Company") (TSX: MDP) (OTCQX: MEDXF) is pleased to announce the appointment of Marcel Konrad as Chief Financial Officer of the Company, effective immediately....

MDP.VN : 7.750 (-4.91%)
MDP.TO : 7.31 (unch)
MEDXF : 5.8850 (+0.42%)
CDNA : 84.04 (-3.97%)
Medexus Pharmaceuticals and medac GmbH enter into Licensing Agreement for First-in-Class Conditioning Agent, Treosulfan, in Canada

Medexus Pharmaceuticals Inc. (the "Company" or "Medexus") (TSX: MDP) (OTCQX: MEDXF) today announced that it has entered into a licensing agreement, formalizing its relationship with medac GmbH ("medac")...

MDP.VN : 7.750 (-4.91%)
MDP.TO : 7.31 (unch)
MEDXF : 5.8850 (+0.42%)
Medexus Receives Notice of Compliance to Commercialize Treosulfan in Canada

Medexus Pharmaceuticals Inc. (the "Company" or "Medexus") (TSX: MDP) (OTCQX: MEDXF) today announced that it has received a Notice of Compliance ("NOC") from Health Canada to commercialize treosulfan, developed...

MDP.VN : 7.750 (-4.91%)
MDP.TO : 7.31 (unch)
MEDXF : 5.8850 (+0.42%)
Medexus Revenue Increases 43.5% to a Record US$79.7 Million for Fiscal 2021

Transformative licensing agreement for treosulfan in the U.S. completed February 2, 2021

MDP.VN : 7.750 (-4.91%)
MDP.TO : 7.31 (unch)
MEDXF : 5.8850 (+0.42%)
Medexus Announces Graduation to the Toronto Stock Exchange

Medexus Pharmaceuticals Inc. ("Medexus" or the "Company") (TSXV:MDP) (OTCQX: MEDXF) announced today that it has received final approval for listing of the Company's common shares (the "Common Shares")...

MDP.VN : 7.750 (-4.91%)
MEDXF : 5.8850 (+0.42%)
Medexus to Present at Raymond James Human Health Innovation Conference

Medexus Pharmaceuticals Inc. (the "Company" or "Medexus") (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) announced today that it will be presenting at the Raymond James Human Health Innovation Conference...

MDP.VN : 7.750 (-4.91%)
MEDXF : 5.8850 (+0.42%)
Medexus Schedules Fiscal Year 2021 Conference Call

June 11, 2021 - Medexus Pharmaceuticals Inc. (the "Company" or "Medexus") (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) today announced that it plans to host a conference call at 8:00 AM Eastern Time on...

MDP.VN : 7.750 (-4.91%)
MEDXF : 5.8850 (+0.42%)
Medexus Strengthens Medical Affairs Team in Preparation for Planned Treosulfan Launch

Medexus Pharmaceuticals Inc. (the "Company" or "Medexus") (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) today announced that it has expanded its medical affairs team in preparation for the planned launch...

MDP.VN : 7.750 (-4.91%)
MEDXF : 5.8850 (+0.42%)
Medexus Announces Availability of Triamcinolone Hexacetonide in the United States

Medexus Pharmaceuticals Inc. (the "Company" or "Medexus") (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) announced today that it is initiating immediate availability of Triamcinolone Hexacetonide Injectable...

MDP.VN : 7.750 (-4.91%)
MEDXF : 5.8850 (+0.42%)
Medexus to Present at The LD Micro Virtual Invitational XI on June 8th

Medexus Pharmaceuticals Inc. (the "Company" or "Medexus") (TSXV: MDP, OTCQX: MEDXF), today announced that management will present at the LD Micro Invitational XI investor conference taking place virtually...

MDP.VN : 7.750 (-4.91%)
MEDXF : 5.8850 (+0.42%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 6.1500
2nd Resistance Point 6.0350
1st Resistance Point 5.9600
Last Price 5.8850
1st Support Level 5.7700
2nd Support Level 5.6550
3rd Support Level 5.5800

See More

52-Week High 7.7600
Last Price 5.8850
Fibonacci 61.8% 5.5635
Fibonacci 50% 4.8850
Fibonacci 38.2% 4.2065
52-Week Low 2.0100

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar